Louisiana Administrative Code
Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS
Part XCI - Drug and Device Distributors
Chapter 1 - General Provisions
Section XCI-105 - Exemptions
Universal Citation: LA Admin Code XCI-105
Current through Register Vol. 50, No. 9, September 20, 2024
A. Distribution does not include:
1. intra -company
distribution to licensed drug or device distributors physically located in
Louisiana;
2. the distribution of a
drug or device or an offer to distribute a drug or device by a charitable
organization described in section
501(c)(3) of the
Internal Revenue Code of 1954 to a nonprofit affiliate of the organization to
the extent otherwise permitted by law;
3. the distribution of a drug or device or an
offer to distribute a drug or device among hospitals or other health care
entities that are under common ownership;
4. the distribution of a drug or device or an
offer to distribute a drug or device for emergency medical reasons including
transfers of drugs or devices by a retail pharmacy to another retail pharmacy
to alleviate a temporary shortage that arises from delays in or interruptions
of regular distribution schedules or a public health emergency
declaration;
5. the dispensing of a
drug or device pursuant to a prescription;
6. the distribution of drug or device samples
by manufacturers' representatives or distributors' representatives;
7. the distribution of blood and blood
components intended for transfusion; or
8. the distribution of legend drugs by retail
pharmacies to licensed practitioners for office use where the annual dollar
volume of legend drugs sold to licensed practitioners does not exceed five
percent of the dollar volume of that retail pharmacy's annual legend drug
sales.
9. the distribution of
devices by manufacturers sales representatives during transportation to
customers;
10. the distribution of
a software utilized in a non-emergency, delayed patient monitoring system to be
used in remote monitoring not intended to provide real time integrated data
from a continuous or long-time, non-invasive patient monitoring device, and
that has been previously approved by the appropriate federal agency; this
exemption shall not be deemed to prohibit regulation in accordance with
quarantine statutes.
B. Wholesale distribution does not include:
1.
intra-company distribution between members of an affiliate or within a
manufacturer;
2. the distribution
of or offer to distribute among hospitals or other health care entities which
are under common control;
3. the
distribution or offer to distribute for emergency medical reasons including a
public health emergency declaration, except that a drug shortage not caused by
a public health emergency shall not constitute an emergency medical
reason;
4. the dispensing pursuant
to a prescription;
5. the
distribution of minimal quantities by a licensed retail pharmacy to a licensed
practitioner for office use;
6. the
distribution or offer to distribute by charitable organizations to nonprofit
affiliates of the organization;
7.
the purchase or other acquisition by a retail dispenser, hospital, or other
health care entity for use by such retail dispenser, hospital, or other health
care entity;
8. the distribution by
the manufacturer;
9. the receipt or
transfer by an authorized third-party logistics provider provided that such
third-party logistics provider does not take ownership;
10. a common carrier that transports a drug
product, provided that the common carrier does not take ownership;
11. the distribution or offer to distribute
by an authorized repackager that has taken ownership or possession and
repacks;
12. salable drug product
returns when conducted by a retail dispenser;
13. the distribution of a collection of
finished medical devices, which may include a product or biological product,
assembled in kit form strictly for the convenience of the purchaser or user,
if:
a. the kit is assembled in an
establishment registered with FDA as a device manufacturer;
b. the kit does not contain a controlled
substance that appears in a schedule contained in the Comprehensive Drug Abuse
Prevention and Control Act of 1970 and any amendments to;
c. the kit includes a product, the person
that manufacturers the kit:
i. purchased
directly from the manufacturer or from a wholesale distributor that purchased
directly from the manufacturer, and
ii. does not alter the primary container or
label of the product as purchased from the manufacturer or wholesale
distributor; and
d. kits
that include a product and the product is:
i.
an intravenous solution intended for replenishment of fluids and
electrolytes;
ii. intended to
maintain the equilibrium of water and minerals in the body;
iii. intended for irrigation or
reconstitution;
iv. an
anesthetic;
v. an
anticoagulant;
vi. a vasopressor,
or
vii. a
sympathomimetic;
14. the distribution of an intravenous drug
that by its formulation is intended for the replenishment of fluids and
electrolytes or calories;
15. the
distribution of an intravenous drug used to maintain the equilibrium of water
and minerals in the body;
16. the
distribution of a drug intended for irrigation, or sterile water, whether
intended for such purposes or for injection;
17. the distribution of medical
gas;
18. facilitating the
distribution by providing solely administrative services including processing
orders and payments; or
19. the
transfer by a hospital or other health care entity, or by a wholesale
distributor or manufacturer operating at the direction of the hospital, or
other health care entity, to a repackager who is registered for the purpose of
repackaging for use by the hospital, or other heath care entity, and other
health care entities that are under common control, if ownership of the drug
remains with the hospital or other health care entity at all times.
AUTHORITY NOTE: Promulgated in accordance with R.S. 37:3461-3482.
Disclaimer: These regulations may not be the most recent version. Louisiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.